NDC11 51824010503

This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.

Possible FDA NDC forms#

Package NDC, Product root table
Package NDCProduct root
51824-0105-0351824-0105
51824-0105-351824-0105
51824-105-0351824-105

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TorvexDICLOFENAC SODIUM AND MENTHOL, METHYL SALICYLATEFlorrax Pharmaceutical55a35d04-d75b-4e76-972f-4710035763c92026-08-06Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 51824-105-03
ndc11 (package): 51824010503
OrthrexoDICLOFENAC SODIUM AND MENTHOL, METHYL SALICYLATEV2 Pharma, LLCeb070904-4f6f-42c0-981d-8dc8500401852026-04-02Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 51824-105-03
ndc11 (package): 51824010503
CAREALL Muscle Rub Ultra StrengthMENTHOL, METHYL SALICYLATENew World Imports, Incd066002d-8ceb-4d16-9744-d5ca25d2ad5a2025-12-01WarningsExact identifier
ndc (package): 51824-105-03
ndc (product): 51824-105
ndc11 (package): 51824010503
OrthaphenDICLOFENAC SODIUM AND MENTHOL, METHYL SALICYLATEV2 Pharma, LLC1583e691-5823-4a68-aafc-bf80b88542332025-07-28Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 51824-105-03
ndc11 (package): 51824010503
FenovarDICLOFENAC SODIUM AND MENTHOL, METHYL SALICYLATEV2 Pharma, LLCcca25bd7-2afd-4ff1-adb3-0a77dfcd43422024-11-01Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 51824-105-03
ndc11 (package): 51824010503

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.